Байер и Монсанто подтвердили продвинутые переговоры о слиянии по цене 127,50 доллара за акцию

Here’s the latest update on the proposed Bayer acquisition of Monsanto with published statements from each. From Bayer: Bayer confirms advanced negotiations with Monsanto concerning a proposed transaction. While key terms and conditions have not yet been agreed, Bayer would be prepared to provide a transaction consideration of USD 127.50 per Monsanto share only in connection with a negotiated transaction. There can be no assurance that the parties will enter into an agreement. The proposed transaction would be subject to regulatory approval and other customary closing conditions. The key conditions of a definitive transaction agreement must be approved by the Supervisory Board of Bayer AG. For more information please visit: www.advancingtogether.com From Monsanto: Monsanto Company (NYSE:MON) confirmed it has been engaged in constructive negotiations with Bayer AG, during which it has received an updated non-binding proposal for a potential acquisition of Monsanto for $127.50 per share in cash. Monsanto is continuing these conversations as it evaluates this proposal, as well as proposals from other parties and other strategic alternatives to enable its Board of Directors to determine if a transaction in the best interests of its shareowners can be realized. Monsanto will have no further comment at this time. There is no assurance that any transaction will be entered into or consummated, or on what terms.